Literature DB >> 21975017

XVI European Charcot Foundation lecture: nutrition and environment: can MS be prevented?

Kelly Claire Simon1, Kassandra L Munger, Alberto Ascherio.   

Abstract

Multiple sclerosis (MS) is a relatively common debilitating neurologic disease that affects people in early adulthood. While the characteristic pathology of MS has been well described, the etiology of the disease is not well understood, despite decades of research and the identification of strong genetic and environmental candidates for susceptibility. A question central to all diseases, but posed specifically for MS at the XVI European Charcot Foundation Lecture, was 'Can MS be prevented?' To address this question, we have evaluated the available data regarding nutritional and environmental factors that may be related to MS susceptibility and suggest the extent to which a potential intervention may reduce disease burden. It is our opinion that intervention, particularly supplementation with vitamin D, could have a dramatic impact on disease prevalence. Understanding that any intervention or behavioral modification will surely act in the context of genetic susceptibility and unidentified stochastic events, it is likely that not all MS is 'preventable'. Epidemiologic observation has provided key insights into environmental and nutritional factors that may alter one's susceptibility to MS, however, there are still many questions in unraveling the etiology of this complex disease.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21975017      PMCID: PMC3351205          DOI: 10.1016/j.jns.2011.09.009

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  131 in total

1.  The distinction blurs between an autoimmune versus microbial hypothesis in multiple sclerosis.

Authors:  D A Hafler
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

2.  Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle.

Authors:  M T Kampman; T Wilsgaard; S I Mellgren
Journal:  J Neurol       Date:  2007-03-21       Impact factor: 4.849

3.  Nutritional factors in the aetiology of multiple sclerosis: a case-control study in Montreal, Canada.

Authors:  P Ghadirian; M Jain; S Ducic; B Shatenstein; R Morisset
Journal:  Int J Epidemiol       Date:  1998-10       Impact factor: 7.196

4.  Studies in the epidemiology of multiple sclerosis in the Orkney and Shetland Islands.

Authors:  D C Poskanzer; A M Walker; J Yonkondy; J L Sheridan
Journal:  Neurology       Date:  1976-06       Impact factor: 9.910

5.  Lymphoblastoid cell lines and Burkitt-lymphoma-derived cell lines differ in the expression of a second Epstein-Barr virus encoded nuclear antigen.

Authors:  I Ernberg; B Kallin; J Dillner; K Falk; B Ehlin-Henriksson; M L Hammarskjöld; G Klein
Journal:  Int J Cancer       Date:  1986-11-15       Impact factor: 7.396

6.  Polymorphisms in vitamin D metabolism related genes and risk of multiple sclerosis.

Authors:  K Claire Simon; Kassandra L Munger; Alberto Ascherio
Journal:  Mult Scler       Date:  2009-12-09       Impact factor: 6.312

7.  Estrogen controls vitamin D3-mediated resistance to experimental autoimmune encephalomyelitis by controlling vitamin D3 metabolism and receptor expression.

Authors:  Faye E Nashold; Karen M Spach; Justin A Spanier; Colleen E Hayes
Journal:  J Immunol       Date:  2009-08-26       Impact factor: 5.422

8.  Skin cancer in people with multiple sclerosis: a record linkage study.

Authors:  M J Goldacre; V Seagroatt; D Yeates; E D Acheson
Journal:  J Epidemiol Community Health       Date:  2004-02       Impact factor: 3.710

9.  Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004.

Authors:  Anne C Looker; Christine M Pfeiffer; David A Lacher; Rosemary L Schleicher; Mary Frances Picciano; Elizabeth A Yetley
Journal:  Am J Clin Nutr       Date:  2008-12       Impact factor: 7.045

10.  Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D.

Authors:  Sreeram V Ramagopalan; Narelle J Maugeri; Lahiru Handunnetthi; Matthew R Lincoln; Sarah-Michelle Orton; David A Dyment; Gabriele C Deluca; Blanca M Herrera; Michael J Chao; A Dessa Sadovnick; George C Ebers; Julian C Knight
Journal:  PLoS Genet       Date:  2009-02-06       Impact factor: 5.917

View more
  5 in total

Review 1.  Genetic determinants of risk and progression in multiple sclerosis.

Authors:  Alessandro Didonna; Jorge R Oksenberg
Journal:  Clin Chim Acta       Date:  2015-02-04       Impact factor: 3.786

2.  An ImmunoChip study of multiple sclerosis risk in African Americans.

Authors:  Noriko Isobe; Lohith Madireddy; Pouya Khankhanian; Takuya Matsushita; Stacy J Caillier; Jayaji M Moré; Pierre-Antoine Gourraud; Jacob L McCauley; Ashley H Beecham; Laura Piccio; Joseph Herbert; Omar Khan; Jeffrey Cohen; Lael Stone; Adam Santaniello; Bruce A C Cree; Suna Onengut-Gumuscu; Stephen S Rich; Stephen L Hauser; Stephen Sawcer; Jorge R Oksenberg
Journal:  Brain       Date:  2015-03-28       Impact factor: 13.501

3.  Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice.

Authors:  Kerstin Berer; Lisa Ann Gerdes; Egle Cekanaviciute; Xiaoming Jia; Liang Xiao; Zhongkui Xia; Chuan Liu; Luisa Klotz; Uta Stauffer; Sergio E Baranzini; Tania Kümpfel; Reinhard Hohlfeld; Gurumoorthy Krishnamoorthy; Hartmut Wekerle
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-11       Impact factor: 11.205

4.  CD6 gene polymorphism rs17824933 is associated with multiple sclerosis in Indian population.

Authors:  Mary Anitha D'Cunha; Lekha Pandit; Chaithra Malli
Journal:  Ann Indian Acad Neurol       Date:  2016 Oct-Dec       Impact factor: 1.383

Review 5.  Smoking and microbiome in oral, airway, gut and some systemic diseases.

Authors:  Chunrong Huang; Guochao Shi
Journal:  J Transl Med       Date:  2019-07-15       Impact factor: 5.531

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.